Membrane lymphotoxin is required for resistance to Theiler's virus infection

International Immunology

Volumn 15, Issue 8, 2003, Pages 955-962

  Lin, Xiaoqi ^a   Ma, Xiaoxing ^a   Rodriguez, Moses ^b   Feng, Xuan ^a   Zoecklein, Laurie ^b   Fu, Yang Xin ^a   Roos, Raymond P ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Cytokine; Cytotoxic T lymphocyte; Demyelination; Lymphotoxin; Theiler's virus

Indexed keywords

CD8 ANTIGEN; LYMPHOTOXIN; LYMPHOTOXIN RECEPTOR; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; PROTEIN SUBUNIT; RECEPTOR ANTIBODY; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL MATURATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DEMYELINATION; FEMALE; HAPLOTYPE; IMMUNE RESPONSE; IMMUNE SYSTEM; INFECTION SENSITIVITY; INFLAMMATION; LYMPHOCYTE FUNCTION; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SOLUBILITY; SUPPRESSOR CELL; VIRUS INFECTION; VIRUS RESISTANCE; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, CD; ANTIGENS, VIRAL; CARDIOVIRUS INFECTIONS; DEMYELINATING DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOHISTOCHEMISTRY; KILLER CELLS, NATURAL; LYMPHOTOXIN BETA RECEPTOR; LYMPHOTOXIN-ALPHA; LYMPHOTOXIN-BETA; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SPINAL CORD; T-LYMPHOCYTES, CYTOTOXIC; THEILOVIRUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0042023469     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/mcg094     Document Type: Review

References (46)

1. Roos, R. P. 2002. Pathogenesis of Theiler's murine encephalomyelitis virus-induced disease. In Semler, B. L. and Wimmer, E., eds, The Picornaviruses, p. 427. Plenum Press, New York.
2. Drescher, K. M., Pease, L. R. and Rodriguez, M. 1997. Antiviral immune responses modulate the nature of central nervous system (CNS) disease in a murine model of multiple sclerosis. Immunol. Rev. 159:177.
3. Rodriguez, M., Lindsley, M. D. and Pierce, M. L. 1991. Role of T cells in resistance to Theiler's virus infection. Microb. Pathog. 11:269.
4. Lin, X., Pease, L. R. and Rodriguez, M. 1997. Differential generation of class I H-2D- versus H-2K-restricted cytotoxicity against a demyelinating virus following central nervous system infection. Eur. J. Immunol. 27:963.
5. Lin, X., Roos, R. P., Pease, L. R., Wettstein, P. and Rodriguez, M. 1999. A Theiler's virus alternatively initiated protein inhibits the generation of H-2K-restricted virus-specific cytotoxicity. J. Immunol. 162:17.
6. + T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis. J. Virol. 72:7320.
7. + T lymphocytes provide protection against TMEV-induced demyelinating disease in BALB/c mice. J. Immunol. 156:1276.
8. Njenga, M. K., Pavelko, K. D., Baisch, J., Lin, X., David, C., Leibowitz, J. and Rodriguez, M. 1996. Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice. J. Virol. 70:1729.
9. Drescher, K. M., Murray, P. D., Lin, X., Carlino, J. A. and Rodriguez, M. 2000. TGF-beta 2 reduces demyelination, virus antigen expression, and macrophage recruitment in a viral model of multiple sclerosis. J. Immunol. 164:3207.
10. Lin, X., Sato, S., Patick, A. K., Pease, L. R., Roos, R. P. and Rodriguez, M. 1998. Molecular characterization of a nondemyelinating variant of Daniel's strain of Theiler's virus isolated from a persistently infected glioma cell line. J. Virol. 72:1262.
11. Murray, P. D., McGavern, D. B., Lin, X., Njenga, M. K., Leibowitz, J., Pease, L. R. and Rodriguez, M. 1998. Perforin-dependent neurologic injury in a viral model of multiple sclerosis. J. Neurosci. 18:7306.
12. Rodriguez, M., Pavelko, K. and Coffman, R. L. 1995. Gamma interferon is critical for resistance to Theiler's virus-induced demyelination. J. Virol. 69:7286.
13. Inoue, A., Koh, C, S., Yahikozawa, H., Yanagisawa, N., Yagita, H., Ishihara, Y. and Kim, B. S. 1996. The level of tumor necrosis factor-alpha producing cells in the spinal cord correlates with the degree of Theiler's murine encephalomyelitis virus-induced demyelinating disease. Int. Immunol. 8:1001.
14. Theil, D. J., Tsunoda, I., Libbey, J. E., Derfuss, T. J. and Fujinami, R. S. 2000. Alterations in cytokine but not chemokine mRNA expression during three distinct Theiler's virus infections. J. Neuroimmunol. 104:22.
15. Yamazaki, M., Inoue, A., Koh, C. S., Sakai, T. and Ishihara, Y. 1997. Phosphatidylserine suppresses Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Neuroimmunol. 75:113.
16. Paya, C. V., Patick, A. K., Leibson, P. J. and Rodriguez, M. 1989. Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus. J. Immunol. 143:95.
17. Eugster, H. P., Muller, M., Karrer, U., Car, B. D., Schnyder, B., Eng, V. M., Woerly, G., Le Hir, M., di Padova, F., Aguet, M., Zinkernagel, R., Bluethmann, H. and Ryffel, B. 1996. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-alpha double-deficient mice. Int. Immunol. 8:23.
18. Berger, D. P., Naniche, D., Crowley, M. T., Koni, P. A., Flavell, R. A. and Oldstone, M. B. 1999. Lymphotoxin-beta-deficient mice show defective antiviral immunity. Virology 260:136.
19. + T cell responses and fail to contain virus infection of the central nervous system. J. Immunol. 166:1066.
20. Gately, M. K., Renzetti, L. M., Magram, J., Stern, A. S., Adorini, L., Gubler, J. and Presky, D. H. 1998. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16:495.
21. Fu, Y. X. and Chaplin, D. D. 1999. Development and maturation of secondary lymphoid tissues. Annu. Rev. Immunol. 17:399.
22. Ware, C. F., VanArsdale, T. L., Crowe, P. D. and Browning, J. L. 1995. The ligands and receptors of the lymphotoxin system. Curr. Topics Microbiol. Immunol. 198:175.
23. Fu, Y. X., Molina, H., Matsumoto, M., Huang, G., Min, J. and Chaplin, D. D. 1997. Lymphotoxin-alpha (LT-alpha) supports development of splenic follicular structure that is required for IgG responses. J. Exp. Med. 185:2111.
24. Rennert, P. D., Hochman, P. S., Flavell, R. A., Chaplin, D. D., Jayaraman, S., Browning, J. L. and Fu, Y. X. 2001. Essential role of lymph nodes in contact hypersensitivity revealed in lymphotoxin-alpha-deficient mice. J. Exp. Med. 193:1227.
25. Wu, Q., Wang, Y., Wang, J., Hedgeman, E. O., Browning, J. L. and Fu, Y. X. 1999. The requirement of membrane lymphotoxin for the presence of dendritic cells in lymphoid tissues. J. Exp. Med. 190:629.
26. Nitayaphan, S., Toth, M. M. and Roos, R. P. 1985. Neutralizing monoclonal antibodies to Theiler's murine encephalomyelitis viruses. J. Virol. 53:651.
27. Lin, X., Thiemann, N. R., Pease, L. R. and Rodriguez, M. 1995. VP1 and VP2 capsid proteins of Theiler's virus are targets of H-2D-restricted cytotoxic lymphocytes in the central nervous system of B10 mice. Virology 214:91.
28. Rivera-Quinones, C., McGavern, D., Schmelzer, J. D., Hunter, S. F., Low, P. A. and Rodriguez, M. 1998. Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nat. Med. 4:187.
29. Iizuka, K., Chaplin, D. D., Wang, Y., Wu, Q., Pegg, L. E., Yokoyama, W. M. and Fu, Y. X. 1999. Requirement for membrane lymphotoxin in natural killer cell development. Proc. Natl Acad. Sci. USA. 96:6336.
30. Rennert, P. D., Browning, J. L., Mebius, R., Mackay, F. and Hochman, P. S. 1996. Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs. J. Exp. Med. 184:1999.
31. Rennert, P. D., Browning, J. L. and Hochman, P. S. 1997. Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization. Int. Immunol. 9:1627.
32. De Togni, P., Goellner, J., Ruddle, N. H., Streeter, P. R., Fick, A., Mariathasan, S., Smith, S. C., Carlson, R., Shornick, L. P., Strauss-Schoenberger, J., et al. 1994. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264:703.
33. Banks, T. A., Rouse, B. T., Kerley, M. K., Blair, P. J., Godfrey, V. L., Kuklin, N. A., Bouley, D. M., Thomas, J., Kanangat, S. and Mucenski, M. L. 1995. Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J. Immunol. 155:1685.
34. Koni, P, A., Sacca, R., Lawton, P., Browning, J. L., Ruddle, N. H. and Flavell, R. A. 1997. Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice. Immunity 6:491.
35. Alimzhanov, M. B., Kuprash, D. V., Kosco-Vilbois, M. H., Luz, A., Turetskaya, R. L., Tarakhovsky, A., Rajewsky, K., Nedospasov, S. A. and Pfeffer, K. 1997. Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice. Proc. Natl Acad. Sci. USA 94:9302.
36. Futterer, A., Mink, K., Luz, A., Kosco-Vilbois, M. H. and Pfeffer, K. 1998. The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 9:59.
37. Kirk, C. J., Hartigan-O'Connor, D. and Mule, J. J. 2001. The dynamics of the T-cell antitumor response: chemokine-secreting dendritic cells can prime tumor-reactive T cells extranodally. Cancer Res. 61:8794.
38. Suresh, M., Lanier, G., Large, M. K., Whitmire, J. K., Altman, J. D., Ruddle, N. H. and Ahmed, R. 2002. Role of lymphotoxin alpha in T-cell responses during an acute viral infection. J. Virol. 76:3943.
39. DeGrendele, H. C., Estess, P. and Siegelman, M. H. 1997. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 278:672.
40. Benedict, C. A., Banks, T. A., Senderowicz, L., Ko, M., Britt, W. J., Angulo, A., Ghazal, P. and Ware, C. F. 2001. Lymphotoxins and cytomegalovirus cooperatively induce interferon-beta, establishing host-virus detente. Immunity 15:617.
41. Inoue, A., Koh, C. S., Yamazaki, M. and Yagita, H. 1999. Effect of anti-B7-1 and anti-B7-2 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Immunol. 163:6180.
42. Paya, C. V., Leibson, P. J., Patick, A. K. and Rodriguez, M. 1990. Inhibition of Theiler's virus-induced demyelination in vivo by tumor necrosis factor alpha. Int. Immunol. 2:909.
43. Sean Riminton, D., Korner, H., Strickland, D. H., Lemckert, F. A., Pollard, J. D. and Sedgwick, J. D. 1998. Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice. J. Exp. Med. 187:1517.
44. Chaplin, D. D. and Fu, Y. 1998. Cytokine regulation of secondary lymphoid organ development. Curr. Opin. Immunol. 10:289.
45. Fu, Y. X., Huang, G., Wang, Y. and Chaplin, D. D. 1998. B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin alpha-dependent fashion. J. Exp. Med. 187:1009.
46. Ngo, V. N., Korner, H., Gunn, M. D., Schmidt, K. N., Riminton, D. S., Cooper, M. D., Browning, J. L., Sedgwick, J. D. and Cyster, J. G. 1999. Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J. Exp. Med. 189:403.